Protective Factor for Endometrial Hyperplasia

Endometrial hyperplasia is characterized by the excessive growth of the endometrium (uterine lining), often associated with prolonged exposure to estrogen without adequate opposition from progesterone.

Analysis of Options:

• Diabetes Mellitus: Often associated with conditions like obesity and hormonal disturbances that can increase the risk of endometrial hyperplasia.
• Tamoxifen Therapy: This medication can act like estrogen on the endometrium, thereby increasing the risk of hyperplasia.
• Multiparity: Refers to having had multiple pregnancies. Pregnancy involves significant hormonal shifts, including increased progesterone levels, which are known to counteract estrogen's proliferative effects on the endometrium. Thus, multiparity is considered a protective factor.
• Delayed Menopause: Indicates a longer reproductive period with cumulative estrogen exposure. This extended exposure, particularly if unopposed by progesterone later in life, elevates the risk of endometrial hyperplasia.

Based on the physiological effects, Multiparity is the factor that protects against endometrial hyperplasia.